Research

Research at Yokohama City University

Yokohama City University strives to contribute to the development of arts and sciences, conduct research activities that contribute to advanced technology, and announce research results to the world with high expertise and from a global point of view. We pride ourselves on research that contributes to state-of-the-art technology through specialization and a global outlook. Aiming to contribute to the advancement of science and the global community, we provide support for an array of global standard research programs.

Research Highlights

2022-03-23

The 23rd Comparative Glycome Research Meeting in Yokohama: Glycome Meets Synthetic Biology and Frontiers

On Saturday, August 21, 2021, the 23rd Comparative Glycomics Research Meeting was held at the Training Center of Sail Training Ship NIPPON MARU (Yokohama, Japan). A total of 50 participants onsite and online, including participants from Japan, the United States of America, Belgium, and China, were connected for eight presentations and discussions.
2021-12-02

Comparison of effects of SGLT-2 inhibitors and GLP-1 receptor agonists on cardiovascular and renal outcomes in type 2 diabetes mellitus patients with/without albuminuria: a systematic review and network meta-analysis

It remains unclear which sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are most effective for preventing cardiovascular and renal events in type 2 diabetes mellitus (T2DM) patients, depending on the presence of albuminuria. We conducted a network meta-analysis to compare the efficacy of these two drug classes in T2DM patients with/without albuminuria.
2021-12-02

Systematic review and meta-analysis for prevention of cardiovascular complications using GLP-1 receptor agonists and SGLT-2 inhibitors in obese diabetic patients

Patients with type 2 diabetes mellitus (T2DM) and obesity are at high risk of developing cardiovascular disease (CVD). Both glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter (SGLT-2) inhibitors have been shown to prevent CVD in T2DM patients.
 

Researcher Database

A strong research culture is fostered across all disciplines and all departments in Yokohama City University. To learn more about our faculty and their research, click on the link below.